ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
0,00%
Bitcoin
67.708,03
-0,03%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Myriad Genetics Inc (MYGN)

  7. Myriad Genetics Inc (MYGN) News

MYGN

Myriad Genetics (MYGN)

Myriad Genetics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MYGN
DatumZeitQuelleÜberschriftSymbolFirma
30/05/202423h55GlobeNewswire Inc.QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applicationsNASDAQ:MYGNMyriad Genetics Inc
24/05/202400h00GlobeNewswire Inc.Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual MeetingNASDAQ:MYGNMyriad Genetics Inc
16/05/202422h05GlobeNewswire Inc.New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate CancerNASDAQ:MYGNMyriad Genetics Inc
15/05/202423h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
15/05/202423h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
15/05/202422h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
14/05/202422h26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
13/05/202422h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
13/05/202418h14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
08/05/202414h23IH Market NewsReddit Rises 15% After First Quarterly Report, Upstart and Twilio Plunge Due to Weak Q2 Forecast, and More in EarningsNASDAQ:MYGNMyriad Genetics Inc
08/05/202414h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MYGNMyriad Genetics Inc
07/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MYGNMyriad Genetics Inc
07/05/202422h05GlobeNewswire Inc.Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDANASDAQ:MYGNMyriad Genetics Inc
07/05/202415h00GlobeNewswire Inc.Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict BusinessNASDAQ:MYGNMyriad Genetics Inc
30/04/202422h05GlobeNewswire Inc.Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024NASDAQ:MYGNMyriad Genetics Inc
17/04/202414h00GlobeNewswire Inc.Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health MonitorNASDAQ:MYGNMyriad Genetics Inc
16/04/202415h15GlobeNewswire Inc.New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal ScreenNASDAQ:MYGNMyriad Genetics Inc
09/04/202414h00GlobeNewswire Inc.Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight TestingNASDAQ:MYGNMyriad Genetics Inc
22/03/202402h40GlobeNewswire Inc.Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority DateNASDAQ:MYGNMyriad Genetics Inc
20/03/202421h05GlobeNewswire Inc.Myriad Genetics Announces Patent Granted for SneakPeek® Snap DeviceNASDAQ:MYGNMyriad Genetics Inc
04/03/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
28/02/202414h31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MYGNMyriad Genetics Inc
27/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MYGNMyriad Genetics Inc
27/02/202422h05GlobeNewswire Inc.Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the FoNASDAQ:MYGNMyriad Genetics Inc
27/02/202415h15GlobeNewswire Inc.Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3NASDAQ:MYGNMyriad Genetics Inc
26/02/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
26/02/202422h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
21/02/202422h05GlobeNewswire Inc.Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024NASDAQ:MYGNMyriad Genetics Inc
15/02/202422h05GlobeNewswire Inc.Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s HealthNASDAQ:MYGNMyriad Genetics Inc
14/02/202422h47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MYGNMyriad Genetics Inc
 Showing the most relevant articles for your search:NASDAQ:MYGN

Kürzlich von Ihnen besucht

CCOM
US500
US 500
USOTC
RHHBY
Roche (QX)
TG
ALV
Allianz
AMEX
XLE
Energy Select Sector SPDR
DBI
SDXP
SDAX
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
ETHUSD
Ethereum
NYSE
NKE
Nike
TG
TUI1
Tui
TG
D7G
Nel ASA
TG
DBK
Deutsche Bank
TG
CBK
Commerzbank
USOTC
BASFY
BASF (QX)
TG
LHA
Deutsche Lufthansa
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten